| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C1MB05280B |
| P698 | PubMed publication ID | 21947311 |
| P50 | author | Oleg A. Mayboroda | Q37839418 |
| P2093 | author name string | André M Deelder | |
| Ekaterina Nevedomskaya | |||
| P2860 | cites work | Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy | Q37780690 |
| Metabolomics and detection of colorectal cancer in humans: a systematic review | Q37797462 | ||
| Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. | Q38446388 | ||
| Metabotyping of biofluids reveals stress-based differences in gut permeability in healthy individuals | Q43279696 | ||
| Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles | Q44896606 | ||
| Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles | Q45300045 | ||
| Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. | Q45975618 | ||
| Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease | Q46517994 | ||
| Metabolomic profiling to develop blood biomarkers for Parkinson's disease | Q46789088 | ||
| High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. | Q48844459 | ||
| A 1H-NMR thermometer suitable for cryoprobes. | Q51927331 | ||
| Global metabolic profiling procedures for urine using UPLC–MS | Q58045640 | ||
| Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery | Q58045746 | ||
| Individual Human Phenotypes in Metabolic Space and Time | Q58619089 | ||
| Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice | Q28472438 | ||
| XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification | Q29616057 | ||
| A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules | Q29616473 | ||
| Fusion of mass spectrometry-based metabolomics data | Q31011308 | ||
| Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. | Q33546330 | ||
| Dynamic metabolomic data analysis: a tutorial review | Q33546332 | ||
| Dietary modulation of gut functional ecology studied by fecal metabonomics | Q33679199 | ||
| Multilevel analysis in public health research | Q33960745 | ||
| Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
| Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine | Q34316883 | ||
| Eigenfaces for recognition | Q34365548 | ||
| Metabonomics in toxicology: a review | Q34390625 | ||
| The role of analytical sciences in medical systems biology | Q34551383 | ||
| A practical approach to detect unique metabolic patterns for personalized medicine | Q34754691 | ||
| Human metabolic phenotype diversity and its association with diet and blood pressure. | Q34772005 | ||
| Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra | Q35049286 | ||
| Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis | Q35809534 | ||
| Evidence of different metabolic phenotypes in humans | Q36446294 | ||
| Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? | Q36630007 | ||
| Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics | Q37773335 | ||
| P433 | issue | 12 | |
| P921 | main subject | metabolomics | Q12149006 |
| P304 | page(s) | 3214-3222 | |
| P577 | publication date | 2011-09-22 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | Cross-platform analysis of longitudinal data in metabolomics | |
| P478 | volume | 7 |
| Q114871749 | A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients |
| Q93270326 | Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics |
| Q92440860 | Challenges in Identifying the Dark Molecules of Life |
| Q38547721 | Environmental metabolomics: Biological markers for metal toxicity |
| Q46762192 | Global metabolic profiling of animal and human tissues via UPLC-MS. |
| Q91211251 | Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics |
| Q38059779 | Metabolic phenotyping in clinical and surgical environments |
| Q91544962 | Preoperative Metabolic Signatures of Prostate Cancer Recurrence Following Radical Prostatectomy |
| Q24186492 | Screening with urinary dipsticks for reducing morbidity and mortality |
| Q59136394 | Zebrafish Larvae Are a Suitable Model to Investigate the Metabolic Phenotype of Drug-Induced Renal Tubular Injury |
Search more.